Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Bittium Showcases its Cardiac Products and Solutions at ESC 2022 Congress

Press release Free for publication on August 24, 2022, at 10.00 a.m. (CEST +1) Bittium Showcases its Cardiac Products and Solutions at ESC 2022 Congress  Oulu, Finland, August 24, 2022 – Bittium will participate in the European Society of Cardiology (ESC) Congress held in Barcelona on 26-29 August 2022. The ESC Congress focuses on the research and treatment of cardiovascular diseases, and this year marks 70 years since the first ESC Congress. Bittium’s team of Medical Technologies experts will showcase our latest solutions for cardiac monitoring that enable long-term ECG

More power from smaller motors with new SKF Hybrid deep groove ball bearing

A new high-performance two-piece polymer cage pushes SKF’s Hybrid deep groove ball bearing into new limits and gives more flexibility in the design choices. By allowing higher rotational speeds, it operates more quietly and efficiently than bearings with common cages. Furthermore, it enables higher power density, leading to more power output from the same size electric motor.Gothenburg, Sweden, 24 August 2022: SKF has developed a new hybrid deep groove ball bearing for high-speed applications. The new bearing is aimed at applications such as rail industry traction motors, as well as

BioStock: Stayble sums up and looks ahead

In Stayble Therapeutics’ half-year report, the company’s CEO Andreas Gerward describes 2022 as a successful year so far. Patient recruitment to the phase IIb study with STA363 is progressing at a rapid pace and the last patients are expected to be recruited shortly. In addition, the company plans to intensify partnering activities during the autumn and prepare for the regulatory process in the US, the company’s most important market. Gerward tells us more about the plans and his views on the first half of 2022.Read the full article at biostock.se: https://www.biostock.se/en/2022/08/

SaltX Technology Holding AB Interim report 2 2022

FINANCIAL EVENTS First quarter · Net sales amounted to MSEK 0.1 (0.0) · Operating profit/loss (EBIT) totaled MSEK –16.6 (-7.9) · Cash flow from operating activities amounted to MSEK –14.1 (-10.3) · Earnings per share before and after dilution amounted to SEK -0.16 (-0.08) SIGNIFICANT EVENTS First quarter · SaltX and ABB in cooperation to explore new electrical calcination technology · SaltX project in Luleå takes a new direction toward the steel industry´s green transition · SaltX and Norrenergi in collaboration to reduce C02 emissions from district heating

STENOCARE enters its 4[th] market starting sales in Australia in Q4 2022

NASDAQ FIRST NORTH GROWTH MARKET, DENMARKTICKER:  STENO After securing market access and approvals in both Denmark, Sweden and UK, STENOCARE A/S (“Stenocare”) now takes a first and firm footstep into the southern hemisphere entering Australia. Partnering with the Australian medical cannabis company Cannvalate will help Stenocare embrace a hastily growing market from day one offering Stenocare products to 600 pharmacies and 3,000 doctors. A combined CBD-THC medical cannabis oil will be available for Australian patients already from fourth quarter 2022 with expected sales acceleration in

CS MEDICA signs agreements with two out of the three leading Danish pharmacy chains.

CS MEDICA A/S’s (”CS MEDICA” or the ”Company”) long-awaited breakthrough in the Danish pharmacy world is now a reality, as they close agreements with two out of the three leading pharmacy chains in Denmark.  With this agreement the Company get access to 400 pharmacies in Denmark, with shelf space as well as online availability for the full CANNASEN® CBD product line.Lone Henriksen, CEO CS MEDICA A/S comments “We are proud to announce, that we finally made it to the pharmacies, with agreements signed with two of the three leading pharmacy chains in Denmark.  We will use and optimize this

Atlas Copco to acquire a US based cryostat manufacturer

Nacka, Sweden, August 24 2022: Atlas Copco has agreed to acquire Montana Instruments Corporation. The company provides cryostat solutions for customers involved in physics research and low temperature technology solutions.Montana Instruments Corporation is a privately owned company with 38 employees, located in Bozeman, Montana, USA. In 2021, the company had revenues of approximately MUSD 12 (MSEK 106*). A cryostat is a system used to cool an object to very low temperature and enable measurement of various properties. The Montana Instrument cryostats can attain temperatures down to 4

Immunovia Publishes Interim Report Jan-June 2022

April-June 2022 · Net sales amounted to kSEK 103 (38) divided between sales of tests kSEK 45 and royalties kSEK 58  · Net earnings amounted to MSEK -33 (-49) and ear­nings per share before and after dilution were SEK -1.49 (-2.18) · Cash flow from operating activities amounted to MSEK -41 (-34) · Cash and cash equivalents at the end of the period amounted to MSEK 197 (382) · In April Immunovia submitted the application for CPT PLA Code for the IMMray™ PanCan-d test · The Annual General Meeting on April 7th elected Eric Krafft and Philipp von Hugo as new board members.

Profitability continued to improve, outlook remains positive

Delete Group Oyj Stock Exchange Release       24 August 2022 at 9:30 a.m. EEST                                                         DELETE GROUP OYJ   Interim Financial Statements January–June 2022 (IFRS, IAS 34, unaudited)   PROFITABILITY CONTINUED TO IMPROVE, OUTLOOK REMAINS POSITIVE   In June 2022, Delete announced that it had divested its Recycling Services. The segment is reported in this report in accordance with IFRS 5 “Assets Held for Sale and Discontinued Operations” and is not included in the Interim Financial Statements for Continuing operations. Unless

Half Year Report Scandinavian Enviro Systems AB (publ) January – June 2022

A quarter during which we passed several key milestonesQ2 2022 · Net revenues for the period were MSEK 1.9 (0.5) · Earnings after tax for the period were MSEK -21.3 (-15.3) · Earnings per share for the period (before dilution) was SEK -0.03 (-0.03) · Cash flow for the period after investments was MSEK -25.8 (-15.7) · Enviro granted environmental permit for planned facility in Uddevalla · Enviro’s pyrolysis oil approved under REACH - the company is now to execute a MSEK 2 order · Enviro launches a new branding platform · Michelin presents an even more sustainable

Transactions in connection with share buy-back programme

On 3 March 2022, H+H International A/S (hereinafter referred to as “H+H” or “the Company”) initiated a share buy-back programme in compliance with Article 5 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on Market Abuse and Commission Delegated Regulation (EU) 1052/2016 of 8 March 2016 (the “Safe Harbour Regulation”). The share buy-back programme is expected to be realised over a 12-month period, starting from 4 March 2022. Under the share buy-back programme, H+H may repurchase shares up to a maximum amount of DKK 150 million. Please refer

Qlife Holding AB, Interim report Q2 2022

INCREASED FOCUS ON R&D ROADMAPFINANCIAL SUMMARY – SECOND QUARTER 2022 · Revenue in the period amounted to kSEK 4,025 (10.482). Revenue includes sales of Egoo.Health devices and capsules for the device. The decline in test activity following the end of European Covid restrictions has led to a decline in revenue in line with our expectations.  · EBITDA for the period amounted to kSEK -20,623 (-8,024), and net loss kSEK -20,151 (-8,597).  · The total cash flow in the second quarter amounted to kSEK -8,977 (98,938).  · Earnings per share before/after dilution for the first

Divio Technologies AB (Publ) grows net sales by 12% and expands new sales strategy

SUMMARY OF THE HALF-YEAR REPORT  FOR THE PERIOD 1 JANUARY 2022 TO 30 JUNE 2022 · MRR in June was KUSD 136 (146)  · Net sales increased by 12%, or KSEK 9,035 (8,096)  · Subscription revenue was KSEK 7,628 (7,459)  · Operating loss was KSEK -5,615 (-4,744)  · EBITA was KSEK -5,643 (-5,253)  SIGNIFICANT EVENTS DURING THE HALF YEAR · Onboarded  a large global non-profit organisation  · Achieved ISO 27001 certification  · Strengthened the board of directors with the recruitment of Leif Liljebrunn who also took over as Chairman · Onboarded 4 CloudFlare

Notice of extraordinary general meeting in Qlife Holding AB

The shareholders of Qlife Holding AB, Reg. No. 559224-8040, are hereby invited to attend the extraordinary general meeting to be held on Tuesday 27 September 2022, at 10.00 a.m. at Hetch’s premises at Redaregatan 48 in Helsingborg.The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail. Right to participate and notification Shareholders wishing to participate in the meeting must: · partly be listed in the company’s share register kept by Euroclear Sweden AB as of Monday 19

BoMill Q2 Interim Report, April – June 2022

BoMill AB (”BoMill” or the “Company”) hereby publishes the Interim Report for the period April 1 – June 30, 2022. The Interim Report is available as an attached file to this release and on BoMill’s website. Below is a summary of the report.CEO Andreas Jeppsson comments: “In the second quarter of 2022, our commercial journey really got off to a start, with the solid support of our shareholders. We introduced our high-capacity sorting equipment “BoMill InSight™” to the market, started its field testing and received an order from Gl. Buurholt” Net sales and income for the second quarter (

Atria’s solar power park expansion almost doubles the current panel capacity – the new investment in Nurmo to be commissioned this year

Atria Finland, with Solarigo Systems Oy, will expand its solar power plant at its production facilities in Nurmo. The panel capacity of the current power plant, commissioned in 2018, will almost double. It will produce about 4,250 MWh of solar power per year, which corresponds to the annual consumption of about 2,100 studio apartments. The panel installation started at the beginning of August, and the expansion will be ready for use during 2022. “The use of renewable zero-emission solar energy leads us towards our key goal: Atria’s carbon-neutral food chain. We’ve had nothing but

Nokian Tyres plc: Changes in Nokian Tyres operating model and leadership

Nokian Tyres plc Company Release August 24, 2022 at 9:00 a.m. Nokian Tyres plc is reorganizing the Group's organization and management structure to strengthen go-to-market execution. This is to improve operational efficiency and collaboration, and focus on building the new Nokian Tyres as the company is in the process of investing in new European capacity and exiting Russia. The company is combining Passenger Car Tyres commercial operations under one leadership, with increasing strategic and operational synergies across the geographical areas. Anna Hyvönen, EVP North America, Nordics

Qlife carries out a rights issue of units of approximately SEK 76 million and brings forward the publication of the interim report for the first half of 2022

The board of directors of Qlife Holding AB (“Qlife” or the “Company”) has today, 24 August 2022, subject to approval by the extraordinary general meeting on 27 September 2022, resolved to carry out an issue of units, consisting of shares and warrants, with preferential rights for the Company’s existing shareholders (the “Rights Issue”). The Rights Issue mainly intends to finance the approval of a CRP test for self-test use in the European markets as well as completion and filing of clinical studies for CE approval of a PHE test for self-test use. Members of the Company’s board of directors

Devyser Diagnostics AB publishes Interim Report for the period, January to June 2022

"Devyser reported another quarter of strong organic growth, which again saw record-breaking sales. The gross margin remained high. Both sales and margins have the potential for further improvement as we move forward with the transition from distributor sales to direct sales. Sales for the quarter amounted to SEK 31 million, equal to 42 percent organic growth compared with the same quarter of last year.” Fredrik Alpsten, CEO, Devyser Quarter April-June 2022 · Net sales amounted to SEK 30.9 million (21.8), corresponding to a 41.5% increase. Adjusted for exchange rate

CS MEDICA A/S: TO2 Incentive warrants issued to Diaz Capital Invest AB is exercised with 255,300 shares

CS MEDICA’s (“CS Medica”) incentive program with Diaz Capital Invest AB is now vested with the first portion of the warrants in series TO2 being exercised with 255,300 shares at the strike price of 10.30 DKK per share. The remaing TO3 series warrants, 250,000 shares, can be exercised at a strike price of 31.50 DKK per share if they vest.CS MEDICA currently operates with 3 series of warrants, TO1, TO2 and TO3, in addition to the incentive warrants issued to the management and employees in CS MEDICA: · The TO1 warrants have been submitted to all subscribers of shares in CS Medica´s IPO

CORRECTION TO THE PRESS RELEASE: ALEXANDRIA PANKKIIRILIIKE OYJ:n ACQUISITION OF OWN SHARES 23.08.2022

ALEXANDRIA PANKKIIRILIIKE OYJ NOTIFICATION    24.08.2022 at 09:00 EET   CORRECTION TO THE PRESS RELEASE: ALEXANDRIA PANKKIIRILIIKE OYJ:n ACQUISITION OF OWN SHARES 23.08.2022   REASON: The amount of acquired shares on 23.8.2022 was incorrect   Corrected stock exchange release:   Date 23.08.2022  Exchange transaction Buy  Share class ALEX  Amount 380  Average price/share 7.5771   EURHighest price/share 7.6000   EURLowest price/share 7.5000

There are no items matching the current filter
There are no more items matching the current filter
Back to top